Targeting 17β-estradiol biosynthesis in neural stem cells improves stroke outcome.
Saved in:
| Title: | Targeting 17β-estradiol biosynthesis in neural stem cells improves stroke outcome. |
|---|---|
| Authors: | Patkar S; Strathclyde Institute of Pharmacy and Biological Sciences, University of Strathclyde, Glasgow, United Kingdom., Uwanogho D; Department of Neuroscience, James Black Centre, King's College London, London, United Kingdom., Modo M; Department of Neuroscience, James Black Centre, King's College London, London, United Kingdom.; Department of Radiology, University of Pittsburgh, Pittsburgh, PA, United States., Tate RJ; Strathclyde Institute of Pharmacy and Biological Sciences, University of Strathclyde, Glasgow, United Kingdom., Plevin R; Strathclyde Institute of Pharmacy and Biological Sciences, University of Strathclyde, Glasgow, United Kingdom., Carswell HVO; Strathclyde Institute of Pharmacy and Biological Sciences, University of Strathclyde, Glasgow, United Kingdom. |
| Source: | Frontiers in cellular neuroscience [Front Cell Neurosci] 2022 Jul 22; Vol. 16, pp. 917181. Date of Electronic Publication: 2022 Jul 22 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101477935 Publication Model: eCollection Cited Medium: Print ISSN: 1662-5102 (Print) Linking ISSN: 16625102 NLM ISO Abbreviation: Front Cell Neurosci Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
